Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹13.21 Cr
verified against source
Revenue YoY
—
reported change
EBITDA
₹2.173 Cr
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
Sanjivani Paranteral reported Q4 FY26 consolidated revenue of ₹13.21 crore with EBITDA margin of 15.74% and PAT of ₹0.55 crore. The base business standalone revenue was ₹10.51 crore. Revenue was impacted by geopolitical disruptions in March 2026 due to US-Iran conflict, which halted exports to the Middle East. Management expects normalization in Q1 FY27. The Pune IV fluids facility contributed ₹2.7 crore in Q4, up from ₹1.2 crore in Q3, and management guided for FY27 revenue of ₹60-65 crore from this plant. The base business is expected to deliver ₹80-85 crore in FY27. Key risks include sustained input cost inflation from crude oil and currency volatility, and potential delays in product approvals for the IV facility.
Colored figures show movement against the previous available record.
Guidance to track
- Management guided for base business revenue of ₹80-85 crore in FY27.
- Management guided for Pune IV fluids plant revenue of ₹60-65 crore in FY27.
- Management expects IV facility to achieve EBITDA margins of 17-18% on an annualized basis in FY27.
- Management guided base business EBITDA margins in the range of 15.5-16.5% for FY27.
Risks flagged
- US-Iran conflict disrupted shipping routes and export logistics in March 2026, impacting Q4 revenue. Management has found alternative routes but risks remain.
- Raw material and packing input costs increased in March 2026 due to crude oil price volatility and supply chain disruptions. Management expects some margin pressure.
- Product approvals for the Pune IV plant have been slower than expected due to government process delays. Only 5 products approved out of 23 planned.
- Receivables have increased significantly compared to FY24 levels. Management attributes this to sales growth and customer payment terms, but it remains a risk.
Key quotes
- The situation impacted shipping routes, vessel movement, cargo handling and export logistics across the region. Since the Middle East is a key export market for the company, we were not able to execute exports during the month of March 2026 due to disruption in the shipping and trade movement.
- This year it will be giving a representation in the balance sheet also as our CFO told you very clearly that this year annually we will be doing around a revenue of 60 crores and it will having a profit that will be contributing to the main balance sheet.
- We have found out different routes we are transporting our goods to Saudi Arabia to Turkey and from there we are distributing it and it is cost has also increased in the logistic fair.
Research modules